MCCANN JOE A. 4
4 · POINT Biopharma Global Inc. · Filed Nov 30, 2022
Insider Transaction Report
Form 4
MCCANN JOE A.
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2022-11-29$6.64/sh+2,160$14,342→ 3,616,313 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.639 to $6.640, inclusive. The Reporting Person undertakes to provide to POINT Biopharma Global Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.